These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24992527)

  • 21. Urinary microRNAs as a new class of noninvasive biomarkers in oncology, nephrology, and cardiology.
    Mlcochova H; Hezova R; Meli AC; Slaby O
    Methods Mol Biol; 2015; 1218():439-63. PubMed ID: 25319667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methods of microRNA quantification in urinary sediment.
    Wang G; Szeto CC
    Methods Mol Biol; 2013; 1024():211-20. PubMed ID: 23719954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of urinary microRNAs in chronic kidney disease.
    Beltrami C; Clayton A; Phillips AO; Fraser DJ; Bowen T
    Biochem Soc Trans; 2012 Aug; 40(4):875-9. PubMed ID: 22817751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating and urinary microRNAs in kidney disease.
    Lorenzen JM; Thum T
    Clin J Am Soc Nephrol; 2012 Sep; 7(9):1528-33. PubMed ID: 22580786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetes-associated microRNAs in pediatric patients with type 1 diabetes mellitus: a cross-sectional cohort study.
    Osipova J; Fischer DC; Dangwal S; Volkmann I; Widera C; Schwarz K; Lorenzen JM; Schreiver C; Jacoby U; Heimhalt M; Thum T; Haffner D
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1661-5. PubMed ID: 24937532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Significance of urinary fibrin/fibrinogen degradation products (FDP) measured by highly sensitive ELISA method in various renal diseases].
    Shibata T; Sumie A; Ishii T; Tomo T; Magari Y; Sato J; Yasumori R; Nasu M
    Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):687-94. PubMed ID: 8377281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Percutaneous kidney biopsy: eight years-experience].
    Castro R; Sequeira MJ; Sameiro Faria M; Belmira A; Sampaio S; Roquete P; Silvestre F; Rocha C; Morgado T
    Acta Med Port; 2004; 17(1):20-6. PubMed ID: 15636724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glomerular and tubulointerstitial miR-638, miR-198 and miR-146a expression in lupus nephritis.
    Lu J; Kwan BC; Lai FM; Tam LS; Li EK; Chow KM; Wang G; Li PK; Szeto CC
    Nephrology (Carlton); 2012 May; 17(4):346-51. PubMed ID: 22295894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer.
    Puerta-Gil P; García-Baquero R; Jia AY; Ocaña S; Alvarez-Múgica M; Alvarez-Ossorio JL; Cordon-Cardo C; Cava F; Sánchez-Carbayo M
    Am J Pathol; 2012 May; 180(5):1808-15. PubMed ID: 22426337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating microRNAs as potential biomarkers for nephrotic syndrome.
    Sui W; Lin H; Li H; Yan Q; Chen J; Dai Y
    Iran J Kidney Dis; 2014 Sep; 8(5):371-6. PubMed ID: 25194403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Usefulness of urine analysis in clinical nephrology].
    Jinde K; Endoh M; Sakai H
    Rinsho Byori; 2003 Mar; 51(3):214-8. PubMed ID: 12707993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNAs in kidney disease: an emerging understanding.
    Khella HW; Bakhet M; Lichner Z; Romaschin AD; Jewett MA; Yousef GM
    Am J Kidney Dis; 2013 May; 61(5):798-808. PubMed ID: 23219107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNAs in kidney physiology and disease.
    Trionfini P; Benigni A; Remuzzi G
    Nat Rev Nephrol; 2015 Jan; 11(1):23-33. PubMed ID: 25385286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary cytokines and steroid responsiveness in idiopathic nephrotic syndrome of childhood.
    Woroniecki RP; Shatat IF; Supe K; Du Z; Kaskel FJ
    Am J Nephrol; 2008; 28(1):83-90. PubMed ID: 17914249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinalysis and clinical renal disease.
    Szwed JJ
    Am J Med Technol; 1980 Oct; 46(10):720-5. PubMed ID: 7211937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spectrum of renal diseases in Indian adults.
    Agarwal SK; Dash SC
    J Assoc Physicians India; 2000 Jun; 48(6):594-600. PubMed ID: 11273537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiospecific microRNA plasma levels correlate with troponin and cardiac function in patients with ST elevation myocardial infarction, are selectively dependent on renal elimination, and can be detected in urine samples.
    Gidlöf O; Andersson P; van der Pals J; Götberg M; Erlinge D
    Cardiology; 2011; 118(4):217-26. PubMed ID: 21701171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Messenger RNA expression of target genes in the urinary sediment of patients with chronic kidney diseases.
    Szeto CC; Chan RW; Lai KB; Szeto CY; Chow KM; Li PK; Lai FM
    Nephrol Dial Transplant; 2005 Jan; 20(1):105-13. PubMed ID: 15561743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Differential expressions of miRNAs in kidney in puromycin aminonucleoside nephropathy model and intervened effects of Leizhi capsule].
    Sun W; Li CQ; Chen JH; Shao JD; Zhou D; Zhang L; Gao K
    Zhongguo Zhong Yao Za Zhi; 2013 Jan; 38(1):81-90. PubMed ID: 23596882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased Urinary Levels of
    Martinez-Arroyo O; Ortega A; Galera M; Solaz E; Martinez-Hervas S; Redon J; Cortes R
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32887498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.